Literature DB >> 21382704

Estrogenic activities of Psoralea corylifolia L. seed extracts and main constituents.

Sun-Hye Lim1, Tae-Youl Ha, Jiyun Ahn, Suna Kim.   

Abstract

Estrogenic activities of ethanol extract and its active components from Psoralea corylifolia L. were studied using various in vitro assays. The main components from ethanol extract were analyzed to be bakuchiol, psoralen, isobavachalcone, isobavachromene, and bavachinin. In a fractionation procedure, hexane and chloroform fractions showed estrogenic activity in yeast transactivation assay and E-screen assay. In yeast transactivation assay, ethanol extract, hexane, and chloroform fractions showed significantly higher activities at a concentration of 1.0 ng/ml, and bakuchiol at the concentration of 10(-6) M was showed the highest activity, especially, which was higher than genistein at the same concentration. In E-screen assay, cell proliferation of bakuchiol (10(-6) M) showed similar estrogenic activity with genistein (10(-6) M). In ER binding assay, bakuchiol displayed the strongest ER-binding affinity (IC(50) for ERα=1.01×10(-6) M, IC(50) for ERβ=1.20×10(-6) M) and bakuchiol showed five times higher affinity for ERα than for ERβ.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382704     DOI: 10.1016/j.phymed.2011.02.002

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  23 in total

Review 1.  Isobavachalcone: an overview.

Authors:  Victor Kuete; Louis P Sandjo
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

2.  Effects of bavachin and its regulation of melanin synthesis in A375 cells.

Authors:  Jing-Hua Wang; Yuan-Yuan Pei; Hong-Dan Xu; Li-Jing Li; Ye-Qiu Wang; Guo-Liang Liu; Yan Qu; Ning Zhang
Journal:  Biomed Rep       Date:  2016-05-20

3.  Antiprotozoal screening of traditional medicinal plants: evaluation of crude extract of Psoralea corylifolia against Ichthyophthirius multifiliis in goldfish.

Authors:  Fei Ling; Cheng Lu; Xiao Tu; Yanglei Yi; Aiguo Huang; Qizhong Zhang; Gaoxue Wang
Journal:  Parasitol Res       Date:  2013-04-05       Impact factor: 2.289

4.  The Effect of Salt-Processed Psoralea corylifolia on Generative Organ Targeting.

Authors:  Gen-Hua Zhao; Cui-Ping Yan; Zi-Sheng Xu; Qian-Qian Gao; Zhi-Peng Chen; Wei-Dong Li
Journal:  J Anal Methods Chem       Date:  2016-10-20       Impact factor: 2.193

5.  The Extract of Fructus Psoraleae Promotes Viability and Cartilaginous Formation of Rat Chondrocytes In Vitro.

Authors:  Xin Pan; Kang Xu; Xuefeng Qiu; Wen Zhao; Dong Wang; Li Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

Review 6.  Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.

Authors:  Valentina Echeverria; Florencia Echeverria; George E Barreto; Javier Echeverría; Cristhian Mendoza
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

7.  Effects of sangu decoction on osteoclast activity in a rat model of breast cancer bone metastasis.

Authors:  Bo Deng; Li-Qun Jia; Huang-Ying Tan; Xuan Yao; Fu-Yun Gao; Lin Pan; Jian Cui; Qing Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-06       Impact factor: 2.629

8.  Phytoestrogen Bakuchiol Exhibits In Vitro and In Vivo Anti-breast Cancer Effects by Inducing S Phase Arrest and Apoptosis.

Authors:  Li Li; Xueping Chen; Chi C Liu; Lai S Lee; Cornelia Man; Shuk H Cheng
Journal:  Front Pharmacol       Date:  2016-05-24       Impact factor: 5.810

9.  Quality Assessment of Psoralea fructus by HPLC Fingerprint Coupled with Multi-components Analysis.

Authors:  F Z Yin; L Li; T L Lu; W D Li; B C Cai; W Yin
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

10.  Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B.

Authors:  Najla O Zarmouh; Elizabeth A Mazzio; Faisel M Elshami; Samia S Messeha; Suresh V K Eyunni; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.